SCHEMBL7184330

SCHEMBL7184330

CC(C)Oc1c(C=CC(=O)c2ccc(C(=O)N(C)C)cc2)cc(C(C)(C)C)cc1C(C)(C)C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TNFRSF1A P19438 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
TP53 P04637 1/20 0.38
CYP3A4 P08684 1/20 0.38
MAPT P10636 1/20 0.38
ALOX15 P16050 1/20 0.38
MAPK1 P28482 1/20 0.38
BLM P54132 1/20 0.38
CASP7 P55210 1/20 0.38
HSD17B10 Q99714 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
PTPN1 P18031 4/20 0.37
LMNA P02545 1/20 0.36
HPGD P15428 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
ABCG2 Q9UNQ0 3/20 0.36
KEAP1 Q14145 1/20 0.35
NFE2L2 Q16236 1/20 0.35
EPHX2 P34913 1/20 0.35
NR1H4 Q96RI1 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7184066 0.88 TNFRSF1A (0.48) TNFRSF1ASMN1; SMN2TP53CYP3A4MAPT
SCHEMBL7179060 0.85 CYP1A1 (0.44) TNFRSF1ASMN1; SMN2MAPTLMNAKEAP1
SCHEMBL7186169 0.83 CYP1A1 (0.43) TNFRSF1ASMN1; SMN2TP53CYP3A4MAPT
SCHEMBL7178602 0.83 PTPN1 (0.44) SMN1; SMN2MAPTPTPN1LMNAHPGD
SCHEMBL7177538 0.81 ABCG2 (0.45) PTPN1ABCG2CYP1A1CYP1B1
SCHEMBL7177542 0.81 ABCG2 (0.45) PTPN1ABCG2CYP1A1CYP1B1
SCHEMBL7184621 0.78 CYP1A1 (0.41) MAPTHPGDABCG2CYP1A1CYP1B1
SCHEMBL7188038 0.77 PDE4A (0.38) TNFRSF1ASMN1; SMN2CYP3A4PTPN1HPGD
SCHEMBL7188035 0.77 PDE4A (0.38) TNFRSF1ASMN1; SMN2CYP3A4PTPN1HPGD
SCHEMBL7183816 0.76 KDM4E (0.38) TNFRSF1AMAPTTDP1PTPN1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6603046-B1 The invention is drawn to novel bis-aromatic a, beta -unsaturated ketones. The compounds are useful in the treatment and prophylaxis of diseases caused by parasites or bacteria. LICA PHARMACEUTICALS A/S (DK) 2003-08-05 US disclosed
EP-0634927-B1 TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA LICA PHARMACEUTICALS AS (DK) 2001-07-04 EP disclosed
US-5985935-A PARASITICIDES OR BACTERICIDES STATENS SERUMINSTITUT (DK) 1999-11-16 US disclosed